Computational Models of Adaptive Immunity to Influenza
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Sarah Cobey
2025 – 2029 Continue Reading Computational Models of Adaptive Immunity to Influenza
She/her/hers
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Sarah Cobey
2025 – 2029 Continue Reading Computational Models of Adaptive Immunity to Influenza
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Sarah Cobey
2022 – 2027 Continue Reading Drivers of individual variation in influenza vaccine response and protection from infection
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Sarah Cobey
2020 – 2026 Continue Reading The “Dynamics of the immune responses to repeat influenza vaccination exposures” (DRIVE) Study
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Katelyn Gostic, Sarah Cobey
2019 – 2026 Continue Reading Longitudinal dynamics of protection after influenza infection and vaccination
National Institutes of Health, Nih Office of the Director
People: Marcos Vieira, Sarah Cobey
2014 – 2019 Continue Reading Modeling the Evolutionary Dynamics of Immunity to Influenza for Vaccine Developme
National Institutes of Health, National Institute of General Medical Sciences
People: Sarah Cobey
2011 – 2013 Continue Reading Signatures of Immunity on the Antigenic Diversity of Pathogens
Pillai AN, Park SW, Lipsitch M, Cowling BJ, Cobey S. (2026). Heterogeneity in pre-vaccination population immunity can contribute to variability in vaccine effectiveness estimates. medRxiv : the preprint server for health sciences
Zhong JC, Zhong S, Touyon L, Ho F, Au NYM, Cheng SMS, Ip DKM, Peiris M, Martin ET, Cobey S, Wong SS, Leung NHL, Cowling BJ. (2026). Repeat influenza vaccination effects in 2021/22 and 2022/23 in a community-based cohort in Hong Kong. The Journal of infectious diseases
Loes AN, Tarabi RAL, Li SH, Atkinson RK, Huddleston J, Kikawa C, Griffiths T, Drapeau EM, Wong S-S, Cheng SMS, Leung NHL, Cobey S, Cowling BJ, Bedford T, Hensley SE, Bloom JD. (2026). Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccines. Journal of virology, 100(6)
Ort JT, Sobel Leonard A, Li SH, Atkinson RK, Mendoza LM, Vieira MC, Gang S, Cobey S, Hensley SE. (2026). Cross-reactive human antibody responses to H5N1 influenza virus neuraminidase are shaped by immune history. Nature communications, 17(1)
Park SW, Nielsen BF, Howerton E, Grenfell BT, Cobey S. (2026). Susceptible host dynamics explain pathogen resilience to perturbations. Proceedings of the National Academy of Sciences of the United States of America, 123(1)
Guthmiller JJ, Yu-Ling Lan L, Li L, Fu Y, Nelson SA, Henry C, Stamper CT, Utset HA, Freyn AW, Han J, Stovicek O, Wang J, Zheng NY, Huang M, Dugan HL, Tepora ME, Zhu X, Chen YQ, Palm AE, Shaw DG, Loganathan M, Francis BF, Sun J, Chervin J, Troxell C, Meade P, Leung NHL, Valkenburg SA, Cobey S, Cowling BJ, Wilson IA, García-Sastre A, Nachbagauer R, Ward AB, Coughlan L, Krammer F, Wilson PC. (2025). Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins. Immunity
Billings WZ, Ge Y, Skarlupka AL, Miller SL, Hemme H, John M, Dean NE, Cobey S, Cowling BJ, Shen Y, Ross TM, Handel A. (2025). Different antigenic distance metrics generate similar predictions of influenza vaccine response breadth despite moderate correlation. PLoS computational biology, 21(11)
Park SW, Holmdahl I, Howerton E, Yang W, Baker RE, Vecchi GA, Cobey S, Metcalf CJE, Grenfell BT. (2025). Interplay between climate and childhood mixing can explain a sudden shift in RSV seasonality in Japan. Nature communications
Garretson TA, Liu J, Li SH, Scher G, Santos JJS, Hogan G, Vieira MC, Furey C, Atkinson RK, Ye N, Ort JT, Kim K, Hernandez KA, Eilola T, Schultz DC, Cherry S, Cobey S, Hensley SE. (2025). Immune history shapes human antibody responses to H5N1 influenza viruses. Nature medicine
Yang B, Gostic KM, Adam DC, Zhang R, Einav T, Peng L, Wong SS, Tsang TK, Cummings DAT, Sullivan SG, Cobey S, Cowling BJ. (2025). Breadth of influenza A antibody cross-reactivity varies by virus isolation interval and subtype. Nature microbiology
Park SW, Holmdahl I, Howerton E, Yang W, Baker RE, Vecchi GA, Cobey S, Metcalf CJE, Grenfell BT. (2025). Interplay between climate, childhood mixing, and population-level susceptibility explains a sudden shift in RSV seasonality in Japan. medRxiv : the preprint server for health sciences
Ibiebele JC, Godonou ET, Callear AP, Smith MR, Truscon R, Johnson E, Eisenberg MC, Lauring AS, Monto AS, Cobey S, Martin ET. (2025). The role of viral interaction in household transmission of symptomatic influenza and respiratory syncytial virus. Nature communications, 16(1)
Bi Q, Dickerman BA, Nguyen HQ, Martin ET, Gaglani M, Wernli KJ, Balasubramani GK, Flannery B, Lipsitch M, Cobey S, . (2024). Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection. The Journal of infectious diseases
Loes AN, Tarabi RAL, Huddleston J, Touyon L, Wong SS, Cheng SMS, Leung NHL, Hannon WW, Bedford T, Cobey S, Cowling BJ, Bloom JD. (2024). High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains. Journal of virology
Cowling BJ, Wong SS, Santos JJS, Touyon L, Ort JT, Ye N, Kwok NKM, Ho F, Cheng SMS, Ip DKM, Peiris M, Webby RJ, Wilson PC, Valkenburg SA, Tsang JS, Leung NHL, Hensley SE, Cobey S. (2024). Preliminary findings from the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: a Randomized Controlled Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Park SW, Cobey S, Metcalf CJE, Levine JM, Grenfell BT. (2024). Predicting pathogen mutual invasibility and co-circulation. Science (New York, N.Y.), 386(6718)
McGough L, Cobey S. (2024). A speed limit on serial strain replacement from original antigenic sin. Proceedings of the National Academy of Sciences of the United States of America, 121(25)
Cobey S. (2024). Vaccination against rapidly evolving pathogens and the entanglements of memory. Nature immunology
Kim K, Vieira MC, Gouma S, Weirick ME, Hensley SE, Cobey S. (2024). Measures of Population Immunity Can Predict the Dominant Clade of Influenza A (H3N2) in the 2017-2018 Season and Reveal Age-Associated Differences in Susceptibility and Antibody-Binding Specificity. Influenza and other respiratory viruses, 18(11)
Shaw DG, Aguirre-Gamboa R, Vieira MC, Gona S, DiNardi N, Wang A, Dumaine A, Gelderloos-Arends J, Earley ZM, Meckel KR, Ciszewski C, Castillo A, Monroe K, Torres J, Shah SC, Colombel JF, Itzkowitz S, Newberry R, Cohen RD, Rubin DT, Quince C, Cobey S, Jonkers IH, Weber CR, Pekow J, Wilson PC, Barreiro LB, Jabri B. (2023). Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis. Nature medicine, 29(6)
Kim K, Gouma S, Vieira MC, Weirick ME, Hensley SE, Cobey S. (2023). Measures of population immunity can predict the dominant clade of influenza A (H3N2) and reveal age-associated differences in susceptibility and specificity. medRxiv : the preprint server for health sciences
Vieira MC, Palm AE, Stamper CT, Tepora ME, Nguyen KD, Pham TD, Boyd SD, Wilson PC, Cobey S. (2023). Germline-encoded specificities and the predictability of the B cell response. PLoS pathogens, 19(8)
Tsang TK, Gostic KM, Chen S, Wang Y, Arevalo P, Lau EHY, Cobey S, Cowling BJ. (2023). Investigation of the Impact of Childhood Immune Imprinting on Birth Year-Specific Risk of Clinical Infection During Influenza A Virus Epidemics in Hong Kong. The Journal of infectious diseases, 228(2)
Du Z, Wang L, Pandey A, Lim WW, Chinazzi M, Piontti APY, Lau EHY, Wu P, Malani A, Cobey S, Cowling BJ. (2022). Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India. Nature medicine
Richardson R, Jorgensen E, Arevalo P, Holden TM, Gostic KM, Pacilli M, Ghinai I, Lightner S, Cobey S, Gerardin J. (2022). Tracking changes in SARS-CoV-2 transmission with a novel outpatient sentinel surveillance system in Chicago, USA. Nature communications, 13(1)
Simon V, Kota V, Bloomquist RF, Hanley HB, Forgacs D, Pahwa S, Pallikkuth S, Miller LG, Schaenman J, Yeaman MR, Manthei D, Wolf J, Gaur AH, Estepp JH, Srivastava K, Carreño JM, Cuevas F, , Ellebedy AH, Gordon A, Valdez R, Cobey S, Reed EF, Kolhe R, Thomas PG, Schultz-Cherry S, Ross TM, Krammer F. (2022). PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2. mSphere
Pierce CA, Herold KC, Herold BC, Chou J, Randolph A, Kane B, McFarland S, Gurdasani D, Pagel C, Hotez P, Cobey S, Hensley SE. (2022). COVID-19 and children. Science (New York, N.Y.), 377(6611)
Goyal S, Gerardin J, Cobey S, Son C, McCarthy O, Dror A, Lightner S, Ezike NO, Duffus WA, Bennett AC. (2022). SARS-CoV-2 Infection Among Pregnant People at Labor and Delivery and Changes in Infection Rates in the General Population: Lessons Learned From Illinois. Public health reports (Washington, D.C. : 1974)
Lin Y, Yang B, Cobey S, Lau EHY, Adam DC, Wong JY, Bond HS, Cheung JK, Ho F, Gao H, Ali ST, Leung NHL, Tsang TK, Wu P, Leung GM, Cowling BJ. (2022). Incorporating temporal distribution of population-level viral load enables real-time estimation of COVID-19 transmission. Nature communications, 13(1)
Cobey S, Larremore DB, Grad YH, Lipsitch M. (2021). Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination. Nature reviews. Immunology
Lutrick K, Ellingson KD, Baccam Z, Rivers P, Beitel S, Parker J, Hollister J, Sun X, Gerald JK, Komatsu K, Kim E, LaFleur B, Grant L, Yoo YM, Kumar A, Mayo Lamberte J, Cowling BJ, Cobey S, Thornburg NJ, Meece JK, Kutty P, Nikolich-Zugich J, Thompson MG, Burgess JL. (2021). COVID-19 Infection, Reinfection, and Vaccine Effectiveness in a Prospective Cohort of Arizona Frontline/Essential Workers: The AZ HEROES Research Protocol. JMIR research protocols, 10(6)
Grubaugh ND, Cobey S. (2021). Of variants and vaccines. Cell, 184(26)
Bubar KM, Reinholt K, Kissler SM, Lipsitch M, Cobey S, Grad YH, Larremore DB. (2021). Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science (New York, N.Y.)
Guthmiller JJ, Utset HA, Henry C, Li L, Zheng NY, Sun W, Costa Vieira M, Zost S, Huang M, Hensley SE, Cobey S, Palese P, Wilson PC. (2021). -Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines. mBio
Vieira MC, Donato CM, Arevalo P, Rimmelzwaan GF, Wood T, Lopez L, Huang QS, Dhanasekaran V, Koelle K, Cobey S. (2021). Lineage-specific protection and immune imprinting shape the age distributions of influenza B cases. Nature communications, 12(1)
Bloom JD, Chan YA, Baric RS, Bjorkman PJ, Cobey S, Deverman BE, Fisman DN, Gupta R, Iwasaki A, Lipsitch M, Medzhitov R, Neher RA, Nielsen R, Patterson N, Stearns T, van Nimwegen E, Worobey M, Relman DA. (2021). Investigate the origins of COVID-19. Science (New York, N.Y.), 372(6543)
Clipman SJ, Wesolowski A, Mehta SH, Cobey S, Cummings DAT, Solomon SS. (2021). Improvements in SARS-CoV-2 Testing Cascade in the US: Data from Serial Cross-sectional Assessments. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Holden TM, Richardson RAK, Arevalo P, Duffus WA, Runge M, Whitney E, Wise L, Ezike NO, Patrick S, Cobey S, Gerardin J. (2021). Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020. BMC public health, 21(1)
Cowling BJ, Lim WW, Cobey S. (2021). Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality. Nature medicine
Gostic KM, McGough L, Baskerville EB, Abbott S, Joshi K, Tedijanto C, Kahn R, Niehus R, Hay JA, De Salazar PM, Hellewell J, Meakin S, Munday JD, Bosse NI, Sherrat K, Thompson RN, White LF, Huisman JS, Scire J, Bonhoeffer S, Stadler T, Wallinga J, Funk S, Lipsitch M, Cobey S. (2020). Practical considerations for measuring the effective reproductive number, Rt. PLoS computational biology, 16(12)
Clipman SJ, Wesolowski A, Mehta SH, Agarwal S, Cobey SE, Cummings DAT, Gibson DG, Labrique AB, Kirk GD, Solomon SS. (2020). SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers. medRxiv : the preprint server for health sciences
Cobey S. (2020). Modeling infectious disease dynamics. Science (New York, N.Y.)
Caudill VR, Qin S, Winstead R, Kaur J, Tisthammer K, Pineda EG, Solis C, Cobey S, Bedford T, Carja O, Eggo RM, Koelle K, Lythgoe K, Regoes R, Roy S, Allen N, Aviles M, Baker BA, Bauer W, Bermudez S, Carlson C, Castellanos E, Catalan FL, Chemel AK, Elliot J, Evans D, Fiutek N, Fryer E, Goodfellow SM, Hecht M, Hopp K, Hopson ED Jr., Jaberi A, Kinney C, Lao D, Le A, Lo J, Lopez AG, López A, Lorenzo FG, Luu GT, Mahoney AR, Melton RL, Nascimento GD, Pradhananga A, Rodrigues NS, Shieh A, Sims J, Singh R, Sulaeman H, Thu R, Tran K, Tran L, Winters EJ, Wong A, Pennings PS. (2020). CpG-creating mutations are costly in many human viruses. Evolutionary ecology, 34(3)
Gouma S, Kim K, Weirick ME, Gumina ME, Branche A, Topham DJ, Martin ET, Monto AS, Cobey S, Hensley SE. (2020). Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility. Nature communications, 11(1)
Dugan HL, Guthmiller JJ, Arevalo P, Huang M, Chen YQ, Neu KE, Henry C, Zheng NY, Lan LY, Tepora ME, Stovicek O, Bitar D, Palm AE, Stamper CT, Changrob S, Utset HA, Coughlan L, Krammer F, Cobey S, Wilson PC. (2020). Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans. Science translational medicine, 12(573)
Arevalo P, McLean HQ, Belongia EA, Cobey S. (2020). Earliest infections predict the age distribution of seasonal influenza A cases. eLife, (9)
Gostic KM, McGough L, Baskerville EB, Abbott S, Joshi K, Tedijanto C, Kahn R, Niehus R, Hay J, De Salazar PM, Hellewell J, Meakin S, Munday J, Bosse NI, Sherrat K, Thompson RN, White LF, Huisman JS, Scire J, Bonhoeffer S, Stadler T, Wallinga J, Funk S, Lipsitch M, Cobey S. (2020). Practical considerations for measuring the effective reproductive number, R (t). medRxiv : the preprint server for health sciences
Henry C, Zheng NY, Huang M, Cabanov A, Rojas KT, Kaur K, Andrews SF, Palm AE, Chen YQ, Li Y, Hoskova K, Utset HA, Vieira MC, Wrammert J, Ahmed R, Holden-Wiltse J, Topham DJ, Treanor JJ, Ertl HC, Schmader KE, Cobey S, Krammer F, Hensley SE, Greenberg H, He XS, Wilson PC. (2019). Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals. Cell host & microbe, 25(3)
Ranjeva S, Subramanian R, Fang VJ, Leung GM, Ip DKM, Perera RAPM, Peiris JSM, Cowling BJ, Cobey S. (2019). Age-specific differences in the dynamics of protective immunity to influenza. Nature communications, 10(1), https://github.com/cobeylab/Influenza-immune-dynamics/tree/master/Data
Gouma S, Zost SJ, Parkhouse K, Branche A, Topham DJ, Cobey S, Hensley SE. (2019). Comparison of human H3N2 antibody responses elicited by egg-based, cell-based, and recombinant protein-based influenza vaccines during the 2017-2018 season. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Cai FY, Fussell T, Cobey S, Lipsitch M. (2018). Use of an individual-based model of pneumococcal carriage for planning a randomized trial of a whole-cell vaccine. PLoS computational biology, 14(10)
Wilson PC, Cobey S. (2018). Characterization of the immunologic repertoire: A quick start guide. Immunological reviews, 284(1)
Vieira MC, Zinder D, Cobey S. (2018). Selection and Neutral Mutations Drive Pervasive Mutability Losses in Long-Lived Anti-HIV B-Cell Lineages. Molecular Biology and Evolution, 35(5)
Cobey S, Grad YH. (2018). Response to Skowronski and De Serres. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 67(9)
Cobey S, Gouma S, Parkhouse K, Chambers BS, Ertl HC, Schmader KE, Halpin RA, Lin X, Stockwell TB, Das SR, Landon E, Tesic V, Youngster I, Pinsky BA, Wentworth DE, Hensley SE, Grad YH. (2018). Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 67(3)
Neu KE, Guthmiller JJ, Huang M, La J, Vieira MC, Kim K, Zheng NY, Cortese M, Tepora ME, Hamel NJ, Rojas KT, Henry C, Shaw D, Dulberger CL, Pulendran B, Cobey S, Khan AA, Wilson PC. (2019). Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination. The Journal of clinical investigation, 129(1)
Lewnard JA, Cobey S. (2018). Immune History and Influenza Vaccine Effectiveness. Vaccines, 6(2)
Wen FT, Bell SM, Bedford T, Cobey S. (2018). Estimating Vaccine-Driven Selection in Seasonal Influenza. Viruses, 10(9), https://github.com/cobeylab/flu-vaccine-sieve
Cobey S. (2018). Repeated Vaccination May Protect Children From Influenza Infection. JAMA network open, 1(6)
Cobey S, Baskerville EB, Colijn C, Hanage W, Fraser C, Lipsitch M. (2017). Host population structure and treatment frequency maintain balancing selection on drug resistance. Journal of the Royal Society, Interface, 14(133)
Cobey S. (2017). Sick if you do, sick if you don't. Nature Ecology & Evolution, 1(11)
Baskerville EB, Cobey S. (2017). Does influenza drive absolute humidity?. Proceedings of the National Academy of Sciences of the United States of America, 114(12)
Cobey S, Hensley SE. (2017). Immune history and influenza virus susceptibility. Current Opinion in Virology, (22)
Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE. (2017). Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proceedings of the National Academy of Sciences of the United States of America, 114(47)
Ranjeva SL, Baskerville EB, Dukic V, Villa LL, Lazcano-Ponce E, Giuliano AR, Dwyer G, Cobey S. (2017). Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity. Proceedings of the National Academy of Sciences of the United States of America, 114(51), https://github.com/cobeylab/HPV-model
Wen F, Bedford T, Cobey S. (2016). Explaining the geographical origins of seasonal influenza A (H3N2). Proceedings. Biological sciences, 283(1838)
Lipsitch M, Barclay W, Raman R, Russell CJ, Belser JA, Cobey S, Kasson PM, Lloyd-Smith JO, Maurer-Stroh S, Riley S, Beauchemin CA, Bedford T, Friedrich TC, Handel A, Herfst S, Murcia PR, Roche B, Wilke CO, Russell CA. (2016). Viral factors in influenza pandemic risk assessment. Elife, (5)
Perron GG, Inglis RF, Pennings PS, Cobey S. (2015). Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health. Evolutionary Applications, 8(3)
Childs LM, Baskerville EB, Cobey S. (2015). Trade-offs in antibody repertoires to complex antigens. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 370(1676)
Cobey S, Wilson P, Matsen FA 4th.. (2015). The evolution within us. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 370(1676)
Cobey S. (2014). Pathogen evolution and the immunological niche. Annals of the New York Academy of Sciences, 1320(1)
Cobey S, Lipsitch M. (2012). Pathogen diversity and hidden regimes of apparent competition. The American naturalist, 181(1)
Cobey S, Lipsitch M. (2012). Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science (New York, N.Y.), 335(6074)
Goldstein E, Cobey S, Takahashi S, Miller JC, Lipsitch M. (2011). Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: a statistical method. PLoS medicine, 8(7)
Bedford T, Cobey S, Pascual M. (2011). Strength and tempo of selection revealed in viral gene genealogies. BMC evolutionary biology, (11)
Cobey S, Baskerville EB. (2010). Limits to Causal Inference with State-Space Reconstruction for Infectious Disease. PloS one, 11(12)
Bedford T, Cobey S, Beerli P, Pascual M. (2010). Global migration dynamics underlie evolution and persistence of human influenza A (H3N2). PLoS pathogens, 6(5)
Cobey S, Pascual M. (2011). Consequences of host heterogeneity, epitope immunodominance, and immune breadth for strain competition. Journal of theoretical biology, 270(1)
Cobey S, Pascual M, Dieckmann U. (2010). Ecological factors driving the long-term evolution of influenza's host range. Proceedings. Biological sciences, 277(1695)
Cobey S, Koelle K. (2008). Capturing escape in infectious disease dynamics. Trends in ecology & evolution, 23(10)
Koelle K, Cobey S, Grenfell B, Pascual M. (2006). Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science (New York, N.Y.), 314(5807)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.